David König
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 4
- CAR-T cell therapy research 4
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Sacha I. Rothschild (8 shared papers)Heinz Läubli (9 shared papers)Spasenija Savic Prince (3 shared papers)Alfred Zippelius (4 shared papers)Till Wallrabenstein (2 shared papers)Laura C. Cappelli (1 shared paper)Jarushka Naidoo (1 shared paper)Jinyu Wang (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Lung Cancer (3 papers)Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- SwitzerlandSpainGermany
In The Last Decade
David König
19 papers receiving 244 citations
Peers
Comparison fields: 5 of 45
- Oncology 145
- Immunology 65
- Pulmonary and Respiratory Medicine 95
- Cancer Research 34
- Genetics 14
Countries citing papers authored by David König
This map shows the geographic impact of David König's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David König with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David König more than expected).
Fields of papers citing papers by David König
This network shows the impact of papers produced by David König. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David König. The network helps show where David König may publish in the future.
Co-authors
The 25 scholars most cited alongside David König, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 80 | |
| 2 | 2020 | 35 | |
| 3 | 2022 | 33 | |
| 4 | 2024 | 25 | |
| 5 | 2023 | 15 | |
| 6 | 2021 | 14 | |
| 7 | 2022 | 14 | |
| 8 | 2020 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2024 | 0 |
About David König
David König is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 247 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Diagnosis and Treatment (5 papers), Colorectal Cancer Treatments and Studies (4 papers), CAR-T cell therapy research (4 papers), Lung Cancer Research Studies (4 papers), Immunotherapy and Immune Responses (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (145 citations), Immunology (65 citations), Pulmonary and Respiratory Medicine (95 citations), Cancer Research (34 citations) and Genetics (14 citations). David König has collaborated with scholars based in Switzerland, Spain and Germany. Frequent co-authors include Sacha I. Rothschild, Heinz Läubli, Spasenija Savic Prince, Alfred Zippelius, Till Wallrabenstein, Laura C. Cappelli, Jarushka Naidoo, Jinyu Wang, Robert Ivánek and Anne Bärenwaldt. Their work appears in journals such as Annals of Oncology, Lung Cancer, Pharmacology, Journal of Clinical Oncology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.